Supplements
What Causes High Triglycerides?: Evidence-Based Supplement and Lifestyle Strategies
Nearly 1 in 4 American adults has borderline-high or high triglycerides — yet most are never told why. Elevated triglycerides rarely travel alone: they almost always appear alongside rising inflammatory markers like CRP, homocysteine, and fibrinogen, creating a cardiovascular risk cluster that standard cholesterol panels miss. Understanding the root causes is the first step toward a targeted, personalized fix.

What Causes High Triglycerides? A Biomarker-First Look at Cardiovascular Risk
Triglycerides are the body's preferred form of stored energy — fatty acids packaged into three-molecule chains and tucked away in adipose tissue. When blood levels stay persistently elevated (≥150 mg/dL fasting, with risk accelerating above 200 mg/dL), they signal a deeper metabolic disruption that often extends well beyond fat storage.
Understanding what causes high triglycerides means looking upstream at diet, hormones, genetics, and metabolic health — and downstream at the inflammatory cascade that elevated lipids can trigger. This article walks through the evidence on root causes, the inflammatory biomarkers that tend to co-rise, and the supplement and lifestyle strategies with the strongest clinical support.
---
The Root Causes of High Triglycerides
1. Excess Refined Carbohydrates and Sugar
The liver converts excess dietary carbohydrates — especially fructose from added sugars — into triglycerides through a process called de novo lipogenesis. A landmark controlled feeding study found that replacing 25% of daily energy with fructose increased fasting triglycerides by 36% in just 10 weeks compared to a glucose-matched control, with effects more pronounced in men (Stanhope et al., Journal of Clinical Investigation 2009; PMID: 19381015).
2. Insulin Resistance and Metabolic Syndrome
Insulin normally suppresses lipolysis in fat cells. When cells become insulin resistant, adipose tissue releases free fatty acids into circulation unchecked, flooding the liver with substrate for very-low-density lipoprotein (VLDL) synthesis — the lipoprotein that carries triglycerides into blood. Elevated triglycerides are, in fact, one of the five diagnostic criteria for metabolic syndrome (NIH/NHLBI definition).
3. Alcohol Consumption
Even moderate alcohol intake stimulates hepatic VLDL secretion and blunts lipoprotein lipase activity — the enzyme that clears triglycerides from blood. Heavy drinkers can develop triglycerides exceeding 1,000 mg/dL, a threshold associated with acute pancreatitis risk.
4. Thyroid Dysfunction
Hypothyroidism slows lipoprotein lipase activity and reduces LDL receptor expression, causing triglycerides (along with LDL) to accumulate. A TSH above the optimal range is often the hidden driver of persistently high triglycerides in otherwise healthy adults.
5. Genetic Lipoprotein Disorders
Familial hypertriglyceridemia and familial combined hyperlipidemia are relatively common inherited conditions in which triglycerides remain elevated despite dietary optimization. Genetic panels or thorough family history can flag these cases.
6. Medications
Several common drug classes raise triglycerides as a side effect: thiazide diuretics, beta-blockers, oral estrogens, corticosteroids, atypical antipsychotics, and certain antiretrovirals. Always review the medication list before attributing high triglycerides to lifestyle alone.
---
What Causes High CRP? The Triglyceride–Inflammation Link
C-reactive protein (CRP) is synthesized by the liver in response to cytokines — particularly IL-6 — released during systemic inflammation. Elevated triglycerides and high CRP are strongly correlated because they share a common upstream driver: metabolic dysfunction and excess visceral adiposity.
Visceral fat is metabolically active. It secretes pro-inflammatory adipokines and free fatty acids that stimulate hepatic IL-6 production, which in turn drives up CRP. A meta-analysis of 54 studies confirmed that CRP is an independent predictor of cardiovascular events beyond LDL cholesterol, and that individuals with high triglycerides are significantly more likely to carry elevated CRP (Emerging Risk Factors Collaboration; Lancet 2010; PMID: 20031199).
Optimal high-sensitivity CRP (hsCRP) is below 1.0 mg/L. Values between 1–3 mg/L indicate intermediate risk; above 3 mg/L signals high systemic inflammation that warrants investigation alongside lipid markers.
---
What Causes High Homocysteine? A Parallel Cardiovascular Risk Signal
Homocysteine is an amino acid produced during methionine metabolism. Elevated homocysteine (>10–12 µmol/L) damages endothelial cells, promotes oxidative stress, and accelerates atherosclerotic plaque formation — risks that compound when triglycerides are simultaneously elevated.
The primary causes of high homocysteine include:
- B-vitamin deficiencies — Folate, B12, and B6 are co-factors in homocysteine remethylation and transsulfuration. Deficiency of any one can cause accumulation.
- MTHFR gene variants — The C677T polymorphism reduces enzyme efficiency by 30–65%, impairing folate conversion to its active form (5-MTHF).
- Kidney disease — Reduced renal clearance of homocysteine is a major contributor in chronic kidney disease.
- Hypothyroidism — Again, thyroid dysfunction appears as a driver across multiple cardiovascular risk biomarkers.
A systematic review of 12 randomized controlled trials demonstrated that B-vitamin supplementation (folate + B12 ± B6) reduces homocysteine by an average of 25%, with the greatest effects in individuals with baseline deficiency (Homocysteine Lowering Trialists' Collaboration; BMJ 1998 — foundational trial; extended by Marti-Carvajal et al., Cochrane 2017; doi.org/10.1002/14651858.CD006612.pub5).
While homocysteine-lowering B vitamins have not consistently reduced cardiovascular events in all populations, the evidence supports treating deficiency as part of a comprehensive cardiovascular risk reduction strategy alongside lipid management.
---
What Causes High Fibrinogen? The Clotting Cascade Connection
Fibrinogen is a clotting protein produced by the liver. Chronically elevated fibrinogen (>400 mg/dL) increases blood viscosity and thrombotic risk, and is independently associated with coronary artery disease. Like CRP, fibrinogen is an acute-phase reactant — it rises with inflammation.
What causes high fibrinogen?
- Systemic inflammation (the same metabolic inflammation driving elevated CRP and triglycerides)
- Smoking — one of the most potent fibrinogen-raising exposures
- Obesity and insulin resistance
- Sedentary behavior
- Chronic infection or autoimmune activity
Because fibrinogen and triglycerides share inflammatory and metabolic root causes, improving insulin sensitivity and reducing visceral fat tends to lower both simultaneously. Omega-3 fatty acids, discussed below, have documented effects on both triglycerides and systemic inflammatory markers including fibrinogen.
---
What Causes High ESR? Inflammation's Blunter Measure
Erythrocyte sedimentation rate (ESR) measures how quickly red blood cells settle in a tube — a proxy for the concentration of acute-phase proteins like fibrinogen. ESR is a less specific inflammatory marker than hsCRP but is useful for tracking chronic or systemic inflammation over time.
High ESR (>20 mm/hr in men, >30 mm/hr in women as rough cutoffs) can result from:
- Active autoimmune disease (rheumatoid arthritis, lupus, inflammatory bowel disease)
- Chronic infection
- Anemia (RBCs settle faster)
- Malignancy
- Metabolic inflammation associated with obesity and insulin resistance
In the context of high triglycerides and the inflammatory markers discussed above, an elevated ESR alongside elevated hsCRP and fibrinogen paints a picture of significant systemic inflammation that goes beyond lipid management alone. Addressing the root causes — diet, body composition, glucose regulation, micronutrient status — is required to move all these markers in the right direction simultaneously.
---
Evidence-Based Strategies to Lower Triglycerides (and the Inflammatory Cluster)
Dietary Interventions
- Reduce refined carbohydrates and added sugars. Target <10% of calories from added sugars (American Heart Association guideline). For those with triglycerides >500 mg/dL, fat restriction is also warranted.
- Replace saturated fat with unsaturated fat sources. Mediterranean-style diets lower triglycerides by 10–20% in meta-analyses.
- Limit alcohol. Even a 30-day abstention period can reduce triglycerides by 15–30% in habitual drinkers.
- Increase dietary fiber. Soluble fiber slows glucose absorption, blunting the post-meal triglyceride surge.
Exercise
Aerobic exercise — 150+ minutes per week at moderate intensity — activates lipoprotein lipase and directly lowers triglycerides. A meta-analysis of 27 RCTs found aerobic training reduced fasting triglycerides by an average of 9.9 mg/dL, with greater effects in those with baseline hypertriglyceridemia (Kodama et al., Archives of Internal Medicine 2007; PMID: 17353496).
Supplement Strategies with Clinical Evidence
| Supplement | Clinical Dose | Effect on Triglycerides | Key Evidence |
|---|---|---|---|
| Omega-3 (EPA + DHA) | 2–4 g/day | ↓ 20–30% | Skulas-Ray et al., *Circulation* 2019; PMID: 31422671 |
| Niacin (B3) | 1–3 g/day (extended release) | ↓ 20–50% | AIM-HIGH trial; supervised use required |
| Berberine | 500 mg 2–3×/day | ↓ 17–23% | Lan et al., *J Translational Medicine* 2015; PMID: 25522668 |
| Magnesium | 300–400 mg/day (glycinate) | Improves insulin sensitivity | Guerrero-Romero et al., *Diabetes Metabolism* 2004; PMID: 15272479 |
| CoQ10/Ubiquinol | 100–200 mg/day | Reduces oxidative stress; modest TG effect | Supportive for metabolic syndrome |
Omega-3s deserve special mention. At pharmacological doses (≥2 g/day EPA+DHA), they reduce hepatic VLDL synthesis and enhance triglyceride clearance. A 2019 AHA Science Advisory confirmed that 4 g/day prescription omega-3s reduce triglycerides by 20–30% and that even over-the-counter EPA+DHA at lower doses provide meaningful cardiovascular benefit in elevated-risk populations (Skulas-Ray et al., Circulation 2019; PMID: 31422671).
---
What This Means for Your Formula
When Ones analyzes your lab results — including fasting triglycerides, hsCRP, homocysteine, and lipid fractions — the AI identifies whether elevated triglycerides are appearing in isolation or as part of a broader inflammatory and metabolic cluster. That distinction shapes which ingredients are prioritized in your custom capsule formula.
For individuals with elevated triglycerides and systemic inflammation markers, Ones commonly includes:
- Omega-3 (EPA/DHA) dosed to clinical ranges — matching the 2–4 g/day threshold shown in the literature to meaningfully lower triglycerides and hsCRP simultaneously. This is the highest-priority single ingredient for hypertriglyceridemia.
- Heart Support (proprietary blend) — Ones' Heart Support System Blend is formulated to address multiple cardiovascular risk factors, combining ingredients that support endothelial function, lipid metabolism, and vascular tone rather than targeting triglycerides alone.
- Berberine — When insulin resistance or metabolic syndrome markers are present alongside elevated triglycerides, berberine's dual action on lipid metabolism and glucose regulation makes it a high-value inclusion at clinically validated doses.
Because Ones formulas are calibrated to your biomarker findings — not a generic wellness template — the specific combination of ingredients and their doses reflect what your data actually shows, not what's popular. If your homocysteine is also elevated, B-vitamin co-factors enter the formula. If hsCRP signals active systemic inflammation, the formula shifts accordingly.
For a deeper look at how inflammatory markers interact with lipid health, see our guide on understanding cardiovascular biomarkers and inflammation and our breakdown of omega-3 dosing for triglycerides and heart health.
If you're also managing blood sugar alongside lipid concerns, our article on berberine for metabolic syndrome covers the mechanistic evidence in detail.
---
Key Takeaways
- High triglycerides are almost always metabolic in origin — excess refined carbohydrates, insulin resistance, alcohol, thyroid dysfunction, and genetics are the leading drivers.
- Elevated triglycerides rarely travel alone — they frequently co-occur with high hsCRP, elevated homocysteine, raised fibrinogen, and high ESR, forming a cardiovascular risk cluster.
- Omega-3 fatty acids at 2–4 g/day (EPA+DHA) are the most evidence-backed supplement for lowering triglycerides, with 20–30% reductions in clinical trials.
- Addressing insulin resistance and visceral fat simultaneously improves triglycerides, CRP, fibrinogen, and ESR — demonstrating that lifestyle changes are foundational, not optional.
- B-vitamin status (folate, B12, B6) should be assessed in anyone with elevated homocysteine alongside triglyceride abnormalities, as deficiency is common and correctable.
- Personalized formulas that map ingredients to your actual biomarker findings — as Ones does — are more effective than generic supplement stacks that ignore the underlying pattern.
Always consult a qualified healthcare provider before making changes to medications or beginning a new supplement protocol, particularly for triglycerides above 500 mg/dL where pancreatitis risk is elevated.